Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
NCT ID: NCT00830635
Last Updated: 2015-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1800 participants
INTERVENTIONAL
2008-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This randomized clinical trial is studying how well a multimedia educational program works in patients with early-stage prostate cancer or breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Group Therapy Compared With Educational Materials in Patients With Prostate Cancer
NCT00002848
Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making
NCT03116035
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
NCT00372840
Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials
NCT02054715
A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer
NCT00984321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Determine whether an innovative multimedia educational program will help newly diagnosed prostate (project 1) and breast (project 2) cancer patients prepare for their journey as cancer patients, promote informed treatment decision-making and reduce cancer-specific distress, and among breast cancer patients at re-entry, facilitate an informed re-entry transition to cancer survivorship and reduce cancer-specific distress (project 3).
* Determine whether having Cancer Information Service (CIS) Information Specialists make a scheduled telephone callback to callers in project 3 will augment and support use of the CIS Research Consortium (CISRC) multimedia educational programs and further enhance the study outcomes examined in this program of research.
* Determine whether the hypothesized mediational variables account for significant intervention effects in each of the three component projects.
* Examine potential moderator variables to assess potential differences in intervention efficacy by selected subgroups (e.g., age, education) within each component project.
* Conduct an in-depth tracking study of utilization patterns for a detailed description of different patterns of use, as well as elucidating those components or modules within the program that had differential utilization by participants.
* Assist the CIS and other similar cancer information systems in disseminating one or more of the CISRC interventions should they prove effective in this program of research.
Secondary
* Conduct secondary analyses across projects (i.e., perceived need for and benefit from the CISRC interventions and intervention efficacy across three high priority cancer patient populations) that will be made possible by the use of a common theoretical framework, the same or similar intervention and research design across projects, and a common set of endpoints.
OUTLINE: This is a multicenter study.
Patients are assessed by demographic questions and a baseline interview conducted by Cancer Information Service (CIS) Information Specialists.
Patients are randomized to 1 of 3 intervention groups:
* Group 1: Patients receive a mailing containing standard CIS print materials. In project 1, patients receive " Treatment Choices for Men with Early-Stage Prostate Cancer" and "What You Need to Know About Prostate Cancer". In project 2, patients receive "What You Need to Know About Breast Cancer" and "Surgery Choices for Women with Early-Stage Breast Cancer". In project 3, patients receive "Facing Forward: Life After Cancer Treatment" and "What You Need to Know About Breast Cancer".
* Group 2: Patients receive mailings appropriate to their project as in group 1. Patients also receive the multimedia program via the Internet or CD-ROM.
* Group 3: In project 3 only, patients receive mailings appropriate to their project as in group 1 and the multimedia program as in group 2. Patients also receive a CIS callback intervention at 10-14 days from trained Information Specialists from the CIS.
After completion of study therapy, patients are followed at 2 and 9 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
educational intervention
informational intervention
internet-based intervention
questionnaire administration
study of socioeconomic and demographic variables
survey administration
psychosocial assessment and care
quality-of-life assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients are diagnosed with 1 of the following:
* Diagnosis of prostate cancer (project 1)
* Early-stage disease
* Previously untreated disease or treatment status unknown
* Diagnosis of breast cancer (projects 2-3)
* Early-stage disease
* No ductal carcinoma in situ or lobular carcinoma in situ
* Inflammatory breast cancer allowed (project 2)
* Previously untreated disease, receiving concurrent treatment, previously treated disease, or treatment status unknown
* No more than 30 days since completion of treatment OR no more than 6 months post-treatment (project 3)
PATIENT CHARACTERISTICS:
* Has access to a computer
* Willing to provide mailing address and telephone number
* Must be active information-seekers who have already called the CIS
* Understands English
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alfred Marcus, PhD
Role: PRINCIPAL_INVESTIGATOR
AMC Cancer Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida, United States
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCRC-08-0498
Identifier Type: -
Identifier Source: secondary_id
08-0498
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.